Cognizant reports FY2025 revenue of USD 21.11 billion, up 10.5% in Products and Resources segment

Reuters
02/12
Cognizant reports FY2025 revenue of USD 21.11 billion, up 10.5% in Products and Resources segment

Cognizant reported revenues of USD 21.11 billion for the full year ended December 31, 2025, reflecting a 7.0% increase compared to the previous year. Revenue growth was primarily driven by the Financial Services and Health Sciences segments, each contributing significant gains, and the Products and Resources segment, which saw a 10.5% increase supported by the acquisition of Belcan. The Communications, Media and Technology segment experienced modest growth of 1.0%. The company attributed the overall revenue expansion to the ramp-up of several recently secured large deals, particularly in the Financial Services and Health Sciences sectors. In addition, the acquisition of Belcan contributed 260 basis points to overall revenue growth, with the most notable impact on the Products and Resources segment, especially in North America and to a lesser extent in the United Kingdom. Cognizant highlighted its focus on AI-driven solutions, emphasizing its role as an AI builder with expertise at the intersection of industry and technology. The company continues to support clients in modernizing technology, reimagining processes, and transforming experiences in a rapidly evolving business landscape.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cognizant Technology Solutions Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001058290-26-000008), on February 12, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10